Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
Price
Target price
-

-

-
-
-
-
 
WKN: A2ASSB / Name: Noxxon Pharma N.v. / Stock / ? /
Please give a prediction to see the opinions of the community
sharewise uses Wisdom of crowds to gather information regarding a security. Wisdom of crowds works best if you do not see the predictions of others before giving your estimate. Please click one button to see how the community sees this security.

Noxxon Pharma N.v. Stock

So far the community has only identified positive things for Noxxon Pharma N.v. stock. The most positive votes were given for criterium "Worthwhile Investment for the next years".

Pros and Cons of Noxxon Pharma N.v. in the next few years

Pros
?
C******** o* t** e**********
?
W********* I********* f** t** n*** y****
?
B****
Cons
?
M***** P*******
?
S********** s********
?
G***** c******* t* c**********
Tell us your opinion to access the 'Wisdom of the Crowds'

sharewise BeanCounterBot

The analysis provided is generated by an artificial intelligence system and is provided for informational purposes only. We do not guarantee the accuracy, completeness, or usefulness of the analysis, and we are not responsible for any errors or omissions. Use of the analysis is at your own risk.
Last updated at 2023-05-28

Upon an initial glance at the financials of Noxxon Pharma N.V., it is evident that the company is facing challenges from a financial standpoint. With negative total stockholder equity and a decreasing cash position in recent years, Noxxon Pharma N.V. appears to be dealing with financial struggles. However, in order to provide a holistic view and better understand the current financial status of the company, it is essential to delve deeper and explore the pros and cons associated with the company's financial performance.

*Pros: *

Research and Development: The financial statements reveal that Noxxon Pharma N.V. has consistently invested in research and development over the past three years. Having a robust R&D budget is essential for a company in the pharma industry, and this suggests a commitment to innovation and the potential for future growth.